Bill Midgette retired from Porex Corporation in 2016, after serving as president and CEO for 13 years, and following two successful leveraged buyouts. During his tenure, Porex made several successful M&A transactions, on both the buying and selling side, on its way to becoming the global leader in advanced porous polymer solutions.
Bill has served as managing director for subsidiary companies in Japan, China, Germany, U.K. and Malaysia as has held advisory board positions in industry associations in the U.S. and internationally.
Previously, Bill spent 18 years with C.R.Bard, Inc., where he held several senior executive positions including serving as president of Bard International, Inc., Bard Medical and Bard Japan Ltd. During his tenure, he led the investment, development and commercialization of market-changing products in the cardiovascular, endovascular and urology markets.
Over his career, Bill has executed on development and commercialization of new product technologies, in bioscience, medical and advanced materials markets, through licensing, strategic partnerships, joint ventures and acquisitions. He holds two patents on commercialized medical device technologies, with a third pending.
Bill now leads Fairburn Equity partners, advising early-stage technology companies, and he serves on the Board of GRA-backed Carbice Corporation.
Bill earned his Bachelor of Environmental Studies Degree at the University of Waterloo.